Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Remington, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 57 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Remington, G; Shammi, CM; Sethna, R; Lawrence, R
      Antipsychotic dosing patterns for schizophrenia in three treatment settings

      PSYCHIATRIC SERVICES
    2. Kapur, S; Remington, G
      Atypical antipsychotics (vol 321, pg 1360, 2000)

      BRITISH MEDICAL JOURNAL
    3. Parker, V; Remington, G
      Electroconvulsive therapy in cases of treatment-resistant psychosis

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    4. Remington, G; Khramov, I
      Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychotics

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    5. Remington, G; Sloman, L; Konstantareas, M; Parker, K; Gow, R
      Clomipramine versus haloperidol in the treatment of autistic disorder: A double-blind, placebo-controlled, crossover study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    6. Chong, SA; Remington, G; Mahendran, R; Chua, HC
      Awareness of tardive dyskinesia in Asian patients with schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    7. Kapur, S; Remington, G
      Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia

      ANNUAL REVIEW OF MEDICINE
    8. Remington, G
      Psychopharmacology of antidepressants

      AMERICAN JOURNAL OF PSYCHIATRY
    9. Remington, G
      Psychopharmacology of antipsychotics

      AMERICAN JOURNAL OF PSYCHIATRY
    10. Azorin, JM; Spiegel, R; Remington, G; Vanelle, JM; Pere, JJ; Giguere, M; Bourdeix, I
      A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    11. Kapur, S; Roy, P; Daskalakis, J; Remington, G; Zipursky, R
      Increased dopamine D-2 receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine

      AMERICAN JOURNAL OF PSYCHIATRY
    12. Kapur, S; Remington, G
      Atypical antipsychotics - Patients value the lower incidence of extrapyramidial side effects

      BRITISH MEDICAL JOURNAL
    13. Fitzgerald, PB; Kapur, S; Caligiuri, MP; Jones, C; Silvestri, S; Remington, G; Zipursky, RB
      Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D-2 blockade

      NEUROPSYCHOPHARMACOLOGY
    14. Remington, G
      Schizophrenia: Building and fixing scientific models

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    15. Kapur, S; Wadenberg, ML; Remington, G
      Are animal studies of antipsychotics appropriately dosed?: Lessons from the bedside to the bench

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    16. Chong, SA; Remington, G
      Clozapine augmentation: Safety and efficacy

      SCHIZOPHRENIA BULLETIN
    17. Kapur, S; Zipursky, R; Jones, C; Shammi, CS; Remington, G; Seeman, P
      A positron emission tomography study of quetiapine in schizophrenia - A preliminary finding of an antipsychotic effect with only transiently high dopamine D-2 receptor occupancy

      ARCHIVES OF GENERAL PSYCHIATRY
    18. Kapur, S; Zipursky, R; Jones, C; Remington, G; Houle, S
      Relationship between dopamine D-2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    19. Fitzgerald, PB; Kapur, S; Remington, G; Roy, P; Zipursky, RB
      Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels

      PSYCHOPHARMACOLOGY
    20. Remington, G; Kapur, S
      Atypical antipsychotics: are some more atypical than others?

      PSYCHOPHARMACOLOGY
    21. Remington, G; Chong, SA
      Conventional versus novel antipsychotics: changing concepts and clinical implications

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    22. Remington, G
      Where do the "old" antipsychotics fit in today's treatment plans?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    23. Chong, SA; Remington, G
      Plasma olanzapine and clinical response

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    24. Chong, SA; Remington, G; Tan, CH
      Risperidone treatment of tardive dyskinesia and dystonia

      JOURNAL OF CLINICAL PSYCHIATRY
    25. Remington, G; Kapur, S
      D-2 and 5-HT2 receptor effects of antipsychotics: Bridging basic and clinical findings using PET

      JOURNAL OF CLINICAL PSYCHIATRY
    26. Remington, G; Chong, SA; Kapur, S
      Distinguishing change in primary and secondary negative symptoms

      AMERICAN JOURNAL OF PSYCHIATRY
    27. Kapur, S; Zipursky, RB; Remington, G
      Clinical and theoretical implications of 5-HT2 and D-2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    28. CHONG SA; REMINGTON G
      RE - SERTRALINE-CLOZAPINE INTERACTION

      Canadian journal of psychiatry
    29. PRIMEAU FJ; REMINGTON G
      EVIDENCE THROUGH CLINICAL-EXPERIENCE WITH NOVEL ANTIPSYCHOTICS

      Canadian journal of psychiatry
    30. NAIR NPV; REINER C; REITERSCHMITT B; RONOVSKY K; VYSSOKI D; BAEKE J; DESSEILLES M; KINDTS P; MESOTTEN F; PEUSKENS J; ADDINGTON D; BARUCH P; BEAUCLAIR L; BLOOM D; BOUCHARD RH; FILTEAU M; JEFFRIES J; JONES B; LABELLE A; MAJOR B; NAIR N; POURCHER E; REMINGTON G; RIPLEY C; TOEWS J; VINCENT P; WOLF M; ZIPURSKY R; CHABANNES JM; COHEN C; DUPUY C; LAGHRISSITHODE F; LOMBERTIE E; LUNACEK S; PAGNON I; PUPESCHI G; VANAMERONGEN A; DEMLING J; EBERT D; HUMMEL MM; MAYER G; RETTERATH P; SEIFERT G; WENNHOLD B; ZINZTSCH I; DELZOMPO M; ARDON J; DRIES P; MEULDIJK R; JEPPESEN I; MAHNFELDT M; NERDRUM T; OSBY U
      THERAPEUTIC EQUIVALENCE OF RISPERIDONE GIVEN ONCE-DAILY AND TWICE-DAILY IN PATIENTS WITH SCHIZOPHRENIA

      Journal of clinical psychopharmacology
    31. REMINGTON G; KAPUR S; ZIPURSKY R
      THE RELATIONSHIP BETWEEN RISPERIDONE PLASMA-LEVELS AND DOPAMINE D-2 OCCUPANCY - A POSITRON EMISSION TOMOGRAPHIC STUDY

      Journal of clinical psychopharmacology
    32. REMINGTON G; KAPUR S; ZIPURSKY RB
      PHARMACOTHERAPY OF FIRST-EPISODE SCHIZOPHRENIA

      British Journal of Psychiatry
    33. CHONG SA; REMINGTON G
      ETHNICITY AND CLOZAPINE METABOLISM

      British Journal of Psychiatry
    34. KAPUR S; ZIPURSKY RB; REMINGTON G
      DO LOXAPINE PLUS CYPROHEPTADINE MAKE AN ATYPICAL ANTIPSYCHOTIC - PET ANALYSIS OF THEIR DOPAMINE D-2 AND SEROTONIN(2) RECEPTOR OCCUPANCY

      Archives of general psychiatry
    35. REMINGTON G; KAPUR S; ZIPURSKY R
      APA PRACTICE GUIDELINE FOR SCHIZOPHRENIA - RISPERIDONE EQUIVALENTS

      The American journal of psychiatry
    36. KAPUR S; ZIPURSKY RB; REMINGTON G; JONES C; DASILVA J; WILSON AA; HOULE S
      5-HT2 AND D-2 RECEPTOR OCCUPANCY OF OLANZAPINE IN SCHIZOPHRENIA - A PET INVESTIGATION

      The American journal of psychiatry
    37. TUGG LA; DESAI D; PRENDERGAST P; REMINGTON G; REED K; ZIPURSKY RB
      RELATIONSHIP BETWEEN NEGATIVE SYMPTOMS IN CHRONIC-SCHIZOPHRENIA AND NEUROLEPTIC DOSE, PLASMA-LEVELS AND SIDE-EFFECTS

      Schizophrenia research
    38. KAPUR S; REMINGTON G; JONES C; HOULE S; ZIPURSKY R
      TYPICAL VS.ATYPICAL - LESSONS FROM PET STUDIES OF 5-HT, AND D-2 OCCUPANCY OF ANTIPSYCHOTICS

      Schizophrenia research
    39. REMINGTON G
      CRITICAL ISSUES IN THE TREATMENT OF SCHIZOPHRENIA - BRUNELLO,N, RACAGNI,G, LANGER,SZ, MENDLEWICZ,J

      Canadian journal of psychiatry
    40. SHAMMI CM; REMINGTON G
      CLOZAPINE-INDUCED NECROTIZING COLITIS

      Journal of clinical psychopharmacology
    41. KAPUR S; ZIPURSKY R; REMINGTON G; JONES C; MCKAY G; HOULE S
      PET EVIDENCE THAT LOXAPINE IS AN EQUIPOTENT BLOCKER OF 5-HT2 AND D-2 RECEPTORS - IMPLICATIONS FOR THE THERAPEUTICS OF SCHIZOPHRENIA

      The American journal of psychiatry
    42. KAPUR S; ZIPURSKY R; ROY P; JONES C; REMINGTON G; REED K; HOULE S
      THE RELATIONSHIP BETWEEN D-2 RECEPTOR OCCUPANCY AND PLASMA-LEVELS ON LOW-DOSE ORAL HALOPERIDOL - A PET STUDY

      Psychopharmacology
    43. REMINGTON G; BEZCHLIBNYKBUTLER K
      MANAGEMENT OF ACUTE ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SYNDROMES

      CNS DRUGS
    44. CASEY DE; FLEISCHHACKER WW; REMINGTON G
      QUESTIONS AND ANSWERS

      CNS DRUGS
    45. COLLINS AA; REMINGTON G; COULTER K; BIRKETT K
      DEPRESSION IN SCHIZOPHRENIA - A COMPARISON OF 3 MEASURES

      Schizophrenia research
    46. REMINGTON G; ADAMS M
      RISPERIDONE AND OBSESSIVE-COMPULSIVE SYMPTOMS - REPLY

      Journal of clinical psychopharmacology
    47. KAPUR S; REMINGTON G; JONES C; ROY P; REED K; HOULE S; ZIPURSKY RB
      WHAT IS THE LOWEST EFFECTIVE DOSE OF HALOPERIDOL - EVIDENCE FROM PET STUDIES

      Biological psychiatry
    48. KAPUR S; REMINGTON G; JONES C; WILSON A; DASILVA J; HOULE S; ZIPURSKY R
      HIGH-LEVELS OF DOPAMINE D-2 RECEPTOR OCCUPANCY WITH LOW-DOSE HALOPERIDOL TREATMENT - A PET STUDY

      The American journal of psychiatry
    49. KAPUR S; REMINGTON G
      SEROTONIN-DOPAMINE INTERACTION AND ITS RELEVANCE TO SCHIZOPHRENIA

      The American journal of psychiatry
    50. REMINGTON G
      UNDERSTANDING SCHIZOPHRENIA - THE IMPACT OF NOVEL ANTIPSYCHOTICS

      Canadian journal of psychiatry
    51. KAPUR S; REMINGTON G; ZIPURSKY RB; WILSON AA; HOULE S
      THE D-2 DOPAMINE-RECEPTOR OCCUPANCY OF RISPERIDONE AND ITS RELATIONSHIP TO EXTRAPYRAMIDAL SYMPTOMS - A PET STUDY

      Life sciences
    52. ANNABLE L; JONES B; NAIR V; REMINGTON G; WILLIAMS R
      PSYCHOPHARMACOLOGY

      Journal of psychiatry & neuroscience
    53. REMINGTON G; ADAMS M
      RISPERIDONE AND OBSESSIVE-COMPULSIVE SYMPTOMS

      Journal of clinical psychopharmacology
    54. SCHACHTER D; KLEINMAN I; PRENDERGAST P; REMINGTON G; SCHERTZER S
      THE EFFECT OF PSYCHOPATHOLOGY ON THE ABILITY OF SCHIZOPHRENIC-PATIENTS TO GIVE INFORMED CONSENT

      The Journal of nervous and mental disease
    55. REMINGTON G; FORNAZZARI L; SETHNA R
      PLACEBO-RESPONSE IN REFRACTORY TARDIVE AKATHISIA

      Canadian journal of psychiatry
    56. ADDINGTON DE; JONES B; BLOOM D; CHOUINARD G; REMINGTON G; ALBRIGHT P
      REDUCTION OF HOSPITAL DAYS IN CHRONIC-SCHIZOPHRENIC PATIENTS TREATED WITH RISPERIDONE - A RETROSPECTIVE STUDY

      Clinical therapeutics
    57. BASKYS A; WANG S; REMINGTON G; WOJTOWICZ JM
      HALOPERIDOL AND LOXAPINE BUT NOT CLOZAPINE INCREASE SYNAPTIC RESPONSES IN THE HIPPOCAMPUS

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/02/20 alle ore 08:28:45